linezolid
CHEBI:CHEBI_63607
Definition
An organofluorine compound that consists of 1,3-oxazolidin-2-one bearing an N-3-fluoro-4-(morpholin-4-yl)phenyl group as well as an acetamidomethyl group at position 5. A synthetic antibacterial agent that inhibits bacterial protein synthesis by binding to a site on 23S ribosomal RNA of the 50S subunit and prevents further formation of a functional 70S initiation complex.
Chemical Information
- Molecular Formula
- C16H20FN3O4
- Molecular Mass
- 337.34610
- Charge
- 0
- SMILES
- CC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(N2CCOCC2)c(F)c1
- InChI
- InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1
- InChIKey
- TYZROVQLWOKYKF-ZDUSSCGKSA-N
Alternative Names
- linezolid
- Linezolid
- N-(((S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide
- N-({(5S)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide
Drug Classification
-
acetamidesView Class →
CHEBI:22160
-
morpholinesView Class →
CHEBI:38785
-
oxazolidinoneView Class →
CHEBI:55374
-
organofluorine compoundView Class →
CHEBI:37143
-
t261707
-
t261758
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 190376
- oboInOwl#hasDbXref
- Wikipedia:Linezolid
- core#notation
- CHEBI:63607
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- package_description
- 10 POUCH in 1 CASE (0409-4883-10) / 1 BAG in 1 POUCH / 300 mL in 1 BAG (0409-4883-03)
- package_ndc
- 70771-1111-9
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
- dosage_form
- GRANULE, FOR SUSPENSION
- marketing_start_date
- 20090520
- labeler_name
- Zhejiang Changhai Pharmaceuticals Co., Ltd.
- application_number
- NDA206473
- product_ndc
- 58623-0129
- listing_expiration_date
- 20241231
- route
- INTRAVENOUS
- spl_id
- 369260a2-3528-44e4-aae4-a3191130462e
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 190376
- oboInOwl#hasDbXref
- Wikipedia:Linezolid
- oboInOwl#id
- CHEBI:63607
- oboInOwl#hasAlternativeId
- CHEBI:6477
- generic_name
- LINEZOLID
- brand_name
- Zyvox
- brand_name_base
- Zyvox
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_48001
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- core#notation
- CHEBI:63607
- pharm_class
- Oxazolidinone Antibacterial [EPC]
- pharm_class_cs
- Oxazolidinones [CS]
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- package_marketing_start_date
- 11-SEP-06
- rxcui
- 1662280
- manufacturer_name
- Piramal Critical Care Inc.
- active_ingredient_strength
- 200 mg/100mL
- active_ingredient_name
- LINEZOLID
- unii
- ISQ9I6J12J
- spl_set_id
- c401f1a8-cc37-461b-bfef-f2e156629bf8
- nui
- M0361132
- upc
- 0359762130716
- pharm_class_epc
- Oxazolidinone Antibacterial [EPC]
- has_treatment
- http://purl.obolibrary.org/obo/DOID_401
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect30508
- owl#annotatedSource
- t262872
- owl#someValuesFrom
- t2988528